Cargando…
Post COVID-19 AA amyloidosis of the kidneys with rapidly progressive renal failure
Coronavirus disease 2019 (COVID-19) pandemic has taken the world by a storm, posing a gruelling challenge to the medical fraternity globally. Besides its very high infectivityinfectivity, significant organ dysfunction occurs in critically ill COVID-19 patients, leading to severe morbidity and mortal...
Autores principales: | Mir, Tajamul H., Zargar, Parvaiz A, Sharma, Alok, Jabeen, Bushra, Sharma, Shephali, Parvaiz, M. Omar, Bashir, Sabah, Javeed, Reem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114959/ https://www.ncbi.nlm.nih.gov/pubmed/37055928 http://dx.doi.org/10.1080/19336896.2023.2201151 |
Ejemplares similares
-
Review of eprodisate for the treatment of renal disease in AA amyloidosis
por: Rumjon, Adam, et al.
Publicado: (2012) -
Renal parenchymal calcification secondary to systemic AA amyloidosis
por: Burton, Hannah M.M., et al.
Publicado: (2014) -
Renal AA Amyloidosis in Patients with Type 2 Diabetes Mellitus
por: Díez, Ramón, et al.
Publicado: (2014) -
A Rare Case of Renal AA Amyloidosis Secondary to Sjogren’s Syndrome
por: Costa, Mylene, et al.
Publicado: (2019) -
AA amyloidosis and pyrin gene mutations
por: Konstantopoulos, K., et al.
Publicado: (2005)